Attana to participate at “Affinity 2019” in Stockholm, Sweden June 26th to 28th

The Affinity 2019 conference is organized by the International Society of Molecular Recognition. Attana will participate with a scientific lunch seminar and an exhibition booth to engage industry leaders and researchers.

The Affinity meeting has a long tradition, where scientists (amongst other this year Nobel laureate Gregory Winter) and engineers from academia and industry come together to exchange knowledge in the field of affinity technology, molecular recognition and its application in industry for health and disease, bioprocessing and biosensing. Attana’s participation is a continuation of the company’s ambition to increase the awareness about Attana on the market and to meet with new customers. At the conference Attana will give a scientific presentation about our technology and valuable assays and set up an exhibition. To find out more about the conference and the presenters please follow this link.

For more information, please contact:

Teodor Aastrup, CEO Attana AB
e-mail: teodor.aastrup@attana.com 
tel: + 46 8 674 57 00

The Board of directors for Attana consider that the information in this press release is not likely to have a significant effect on the share prices, but is of general interest for the shareholders and hence should be communicated.

Attana was founded in 2002 with the vision of in-vitro characterization of molecular interactions mimicking in-vivo conditions. Since then, Attana has developed proprietary label free biosensors for biochemical, crude, sera, and cell-based assays. Attana’s products and research services are used by Big Pharma, biotech companies and academic institutions within the life sciences. To learn more about Attana’s contract research services and our label free cell-based biosensors, please visit www.attana.com or contact  sales@attana.com

Tags:

About Us

Attana was founded in 2002 with the vision of in-vitro characterization of molecular interactions mimicking in-vivo conditions. Since then, Attana has developed proprietary label free biosensors for biochemical, crude, sera, and cell-based assays. Attana’s products and research services are used by Big Pharma, biotech companies and academic institutions within the life sciences. To learn more about Attana’s contract research services and our label free cell-based biosensors, please visit www.attana.com or contact sales@attana.com.

Subscribe

Media

Media

Documents & Links